Middle East Conflict Hits Medical Research - Summary - MDSpire
Feature

Middle East Conflict Hits Medical Research

Global analysis reveals thousands of clinical trials have been disrupted by the war

  • April 10, 2026

  • 2 min

Share

A recent analysis by Phesi reveals that 6.7% of 65,061 clinical trials worldwide are disrupted due to conflicts in the Middle East, particularly affecting Phase 3 trials. The Mediterranean countries of Turkey, Israel, and Egypt, alongside the Gulf States and Iraq, have the highest impact. Oncology studies, especially those focused on breast cancer and non-small cell lung cancer, are disproportionately affected. Phesi's CEO, Gen Li, emphasizes the critical need for a data-driven approach to adapt clinical trial strategies while ensuring patient safety and data integrity.

Original Source(s)

Middle East Conflict Hits Medical Research

  • April 10, 2026

Related Content

Combined Tests Could Avoid Unnecessary Cystectomy, Study Finds

Combining a visual inspection of the bladder—systematic endoscopic evaluation—with a blood test to check for the presence of ctDNA may accurately predict which patients with bladder cancer still have ...

Frontline Pharma: Tao Chen

A new series championing scientists in the pharmaceutical industry begins with Genentech’s rising star

How AI Is Already Having a Significant Impact on Cancer Care

Three education sessions presented during the 2025 ASCO Annual Meeting showcased how artificial intelligence (AI) is quickly transforming cancer care from clinical trial planning and ambient scribes t...